Industry experts committed to cures.
Chief Financial Officer
Larry joined AGTC in February 2014. He has more than 30 years of financial executive management experience, including over two decades as a chief financial officer in the biotechnology industry. In his previous positions as Chief Financial Officer, he has successfully navigated the IPO process three times, building a body of expertise in all aspects of the financial management of a biotechnology company, including private and public company financing, SEC reporting, and establishing collaborations and licensing agreements between biotechnology and pharmaceutical companies. Larry also has experience in marketing-based financial analysis, operations management, and sales.
Prior to joining AGTC, Larry was Chief Financial Officer and Corporate Secretary at BioMimetic Therapeutics, Inc., which he successfully took public and after nearly a decade with the company, was instrumental in the process of selling it to Wright Medical in 2013. From 1996 to 2003, he was with Ribozyme Pharmaceuticals, where he served as Chief Financial Officer and also led the company's IPO process. Previously, Larry served as Chief Financial Officer at La Jolla Pharmaceuticals, Inc., which he also took public, and as Chief Financial Officer and a Founding Partner of Natural Products, Inc. Larry's prior experience includes seven years with Warner Lambert, where he held positions of increasing responsibility in cost accounting, international finance and sales. He holds a Bachelor of Arts degree in Business Administration from Indiana University and a Master of Business Administration in Finance and Marketing from the University of Utah.
- Our Team
- Board of Directors
- Scientific Advisors
- Careers and Internships